Siemens Healthineers (OTCMKTS:SEMHF – Get Free Report) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, risk, dividends and analyst recommendations.
Earnings & Valuation
This table compares Siemens Healthineers and Senseonics Holdings, Inc. Common Stock”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Siemens Healthineers | N/A | N/A | N/A | N/A | N/A |
| Senseonics Holdings, Inc. Common Stock | $48.55 million | 7.26 | -$69.11 million | ($2.23) | -3.78 |
Analyst Recommendations
This is a summary of current ratings and price targets for Siemens Healthineers and Senseonics Holdings, Inc. Common Stock, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Siemens Healthineers | 0 | 0 | 0 | 0 | 0.00 |
| Senseonics Holdings, Inc. Common Stock | 1 | 1 | 4 | 0 | 2.50 |
Senseonics Holdings, Inc. Common Stock has a consensus price target of $17.20, suggesting a potential upside of 103.91%. Given Senseonics Holdings, Inc. Common Stock’s stronger consensus rating and higher probable upside, analysts plainly believe Senseonics Holdings, Inc. Common Stock is more favorable than Siemens Healthineers.
Profitability
This table compares Siemens Healthineers and Senseonics Holdings, Inc. Common Stock’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Siemens Healthineers | N/A | N/A | N/A |
| Senseonics Holdings, Inc. Common Stock | -225.09% | -165.80% | -80.14% |
Insider and Institutional Ownership
12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
Senseonics Holdings, Inc. Common Stock beats Siemens Healthineers on 6 of the 9 factors compared between the two stocks.
About Siemens Healthineers
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
About Senseonics Holdings, Inc. Common Stock
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company’s products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.
